NeuBase Therapeutics logo
NeuBase Therapeutics NBSE
$ 0.38 -1.56%

Quarterly report 2023-Q3
added 11-09-2023

report update icon

NeuBase Therapeutics Long Term Debt Current 2011-2024 | NBSE

Annual Long Term Debt Current NeuBase Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
553 K 383 K - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
553 K 383 K 468 K